Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1986 2
1987 1
1988 3
1989 2
1990 1
1991 2
1993 3
1994 1
1995 2
1996 2
1997 4
1998 1
1999 4
2000 8
2001 6
2002 3
2003 8
2004 5
2005 9
2006 8
2007 13
2008 9
2009 16
2010 17
2011 20
2012 23
2013 15
2014 16
2015 17
2016 14
2017 18
2018 13
2019 19
2020 20
2021 20
2022 24
2023 17
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

329 results

Results by year

Filters applied: . Clear all
Page 1
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Smolen JS, Landewé RBM, Bergstra SA, Kerschbaumer A, Sepriano A, Aletaha D, Caporali R, Edwards CJ, Hyrich KL, Pope JE, de Souza S, Stamm TA, Takeuchi T, Verschueren P, Winthrop KL, Balsa A, Bathon JM, Buch MH, Burmester GR, Buttgereit F, Cardiel MH, Chatzidionysiou K, Codreanu C, Cutolo M, den Broeder AA, El Aoufy K, Finckh A, Fonseca JE, Gottenberg JE, Haavardsholm EA, Iagnocco A, Lauper K, Li Z, McInnes IB, Mysler EF, Nash P, Poor G, Ristic GG, Rivellese F, Rubbert-Roth A, Schulze-Koops H, Stoilov N, Strangfeld A, van der Helm-van Mil A, van Duuren E, Vliet Vlieland TPM, Westhovens R, van der Heijde D. Smolen JS, et al. Among authors: balsa a. Ann Rheum Dis. 2023 Jan;82(1):3-18. doi: 10.1136/ard-2022-223356. Epub 2022 Nov 10. Ann Rheum Dis. 2023. PMID: 36357155
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, McInnes IB, Sepriano A, van Vollenhoven RF, de Wit M, Aletaha D, Aringer M, Askling J, Balsa A, Boers M, den Broeder AA, Buch MH, Buttgereit F, Caporali R, Cardiel MH, De Cock D, Codreanu C, Cutolo M, Edwards CJ, van Eijk-Hustings Y, Emery P, Finckh A, Gossec L, Gottenberg JE, Hetland ML, Huizinga TWJ, Koloumas M, Li Z, Mariette X, Müller-Ladner U, Mysler EF, da Silva JAP, Poór G, Pope JE, Rubbert-Roth A, Ruyssen-Witrand A, Saag KG, Strangfeld A, Takeuchi T, Voshaar M, Westhovens R, van der Heijde D. Smolen JS, et al. Among authors: balsa a. Ann Rheum Dis. 2020 Jun;79(6):685-699. doi: 10.1136/annrheumdis-2019-216655. Epub 2020 Jan 22. Ann Rheum Dis. 2020. PMID: 31969328 Free article.
Septic arthritis.
García-Arias M, Balsa A, Mola EM. García-Arias M, et al. Among authors: balsa a. Best Pract Res Clin Rheumatol. 2011 Jun;25(3):407-21. doi: 10.1016/j.berh.2011.02.001. Best Pract Res Clin Rheumatol. 2011. PMID: 22100289 Review.
Teleconsultation in rheumatology: A literature review and opinion paper.
Avouac J, Marotte H, Balsa A, Chebbah M, Clanche SL, Verhagen LAW, Filková M, Mueller RB, Mongey AB, Taylor PC. Avouac J, et al. Among authors: balsa a. Semin Arthritis Rheum. 2023 Dec;63:152271. doi: 10.1016/j.semarthrit.2023.152271. Epub 2023 Sep 27. Semin Arthritis Rheum. 2023. PMID: 37813005 Review.
Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions.
Gil-Guillen VF, Balsa A, Bernárdez B, Valdés Y Llorca C, Márquez-Contreras E, de la Haba-Rodríguez J, Castellano JM, Gómez-Martínez J. Gil-Guillen VF, et al. Among authors: balsa a. Int J Environ Res Public Health. 2022 Sep 23;19(19):12036. doi: 10.3390/ijerph191912036. Int J Environ Res Public Health. 2022. PMID: 36231341 Free PMC article. Review.
Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider.
Krieckaert C, Hernández-Breijo B, Gehin JE, le Mélédo G, Balsa A, Jani M, Mulleman D, Navarro-Compan V, Wolbink G, Isaac J, van Tubergen A. Krieckaert C, et al. Among authors: balsa a. RMD Open. 2022 Jun;8(2):e002216. doi: 10.1136/rmdopen-2022-002216. RMD Open. 2022. PMID: 35980738 Free PMC article. Review.
A paradigm of difficult-to-treat rheumatoid arthritis: subtypes and early identification.
Novella-Navarro M, Ruiz-Esquide V, Torres-Ortiz G, Chacur CA, Tornero C, Fernández-Fernández E, Monjo I, Sanmartí R, Plasencia-Rodríguez C, Balsa A. Novella-Navarro M, et al. Among authors: balsa a. Clin Exp Rheumatol. 2023 May;41(5):1114-1119. doi: 10.55563/clinexprheumatol/7mscci. Epub 2022 Nov 13. Clin Exp Rheumatol. 2023. PMID: 36377568 Free article.
329 results